Laura Pitlik - Jul 12, 2021 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Chief Marketing Officer
Signature
Laura Pitlik, by Attorney-in-Fact, Cesare Suardi
Stock symbol
RKDA
Transactions as of
Jul 12, 2021
Transactions value $
$0
Form type
4
Date filed
7/13/2021, 06:33 PM
Next filing
Apr 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (right to buy) Award $0 +75K $0.00 75K Jul 12, 2021 Common Stock 75K $2.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service.